1-12859061-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_023014.1(PRAMEF2):c.52C>A(p.Leu18Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000499 in 1,604,220 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_023014.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRAMEF2 | NM_023014.1 | c.52C>A | p.Leu18Met | missense_variant | 2/4 | ENST00000240189.2 | NP_075390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRAMEF2 | ENST00000240189.2 | c.52C>A | p.Leu18Met | missense_variant | 2/4 | 1 | NM_023014.1 | ENSP00000240189 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000671 AC: 1AN: 149116Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249650Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135074
GnomAD4 exome AF: 0.00000481 AC: 7AN: 1455104Hom.: 1 Cov.: 33 AF XY: 0.00000691 AC XY: 5AN XY: 723852
GnomAD4 genome AF: 0.00000671 AC: 1AN: 149116Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 72662
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.52C>A (p.L18M) alteration is located in exon 2 (coding exon 1) of the PRAMEF2 gene. This alteration results from a C to A substitution at nucleotide position 52, causing the leucine (L) at amino acid position 18 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at